BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30385747)

  • 1. TRPV4 and KRAS and FGFR1 gain-of-function mutations drive giant cell lesions of the jaw.
    Gomes CC; Gayden T; Bajic A; Harraz OF; Pratt J; Nikbakht H; Bareke E; Diniz MG; Castro WH; St-Onge P; Sinnett D; Han H; Rivera B; Mikael LG; De Jay N; Kleinman CL; Valera ET; Bassenden AV; Berghuis AM; Majewski J; Nelson MT; Gomez RS; Jabado N
    Nat Commun; 2018 Nov; 9(1):4572. PubMed ID: 30385747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Making sense of giant cell lesions of the jaws (GCLJ): lessons learned from next-generation sequencing.
    Gomes CC; Diniz MG; Bastos VC; Bernardes VF; Gomez RS
    J Pathol; 2020 Feb; 250(2):126-133. PubMed ID: 31705763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new TRPV4 mutation in a case of multiple central giant cell granulomas of the jaws.
    Guimarães LM; Martins-Chaves RR; Chabot PQ; Schreuder WH; de Castro WH; Gomez RS; Gomes CC
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Mar; 135(3):e68-e73. PubMed ID: 36529675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo
    Ragamin A; Gomes CC; Bindels-de Heus K; Sandoval R; Bassenden AV; Dib L; Kok F; Alves J; Mathijssen I; Medici-Van den Herik E; Eveleigh R; Gayden T; Pullens B; Berghuis A; van Slegtenhorst M; Wilke M; Jabado N; Mancini GMS; Gomez RS
    J Med Genet; 2022 Mar; 59(3):305-312. PubMed ID: 33685999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated proteomics, phosphoproteomics and metabolomics analyses reveal similarities among giant cell granulomas of the jaws with different genetic mutations.
    Vitório JG; Duarte-Andrade FF; Pereira TDSF; Melo-Braga MN; Canuto GAB; Macedo AN; Lebron YAR; Moreira VR; Felicori LF; Lange LC; Santos LVS; Larsen MR; Gomes CC; Gomez RS
    J Oral Pathol Med; 2022 Aug; 51(7):666-673. PubMed ID: 35706152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KRAS mutations in brown tumor of the jaws in hyperparathyroidism.
    Guimarães LM; Gomes IP; Pereira TDSF; de Andrade BAB; Romañach MJ; de Lacerda JCT; Pontes HAR; Brennan PA; Rahimi S; Carlos R; Mosqueda-Taylor A; Bologna-Molina R; Passador-Santos F; Gomez RS; Gomes CC
    J Oral Pathol Med; 2020 Sep; 49(8):796-802. PubMed ID: 32492752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KRAS mutations in implant-associated peripheral giant cell granuloma.
    Martins-Chaves RR; Guimarães LM; Pereira TDSF; Pereira NB; Chrcanovic BR; Fonseca FP; Lafuente-Ibáñez de Mendoza I; Aguirre-Urizar JM; Gomes CC; Gomez RS
    Oral Dis; 2020 Mar; 26(2):334-340. PubMed ID: 31758745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline and somatic FGFR1 abnormalities in dysembryoplastic neuroepithelial tumors.
    Rivera B; Gayden T; Carrot-Zhang J; Nadaf J; Boshari T; Faury D; Zeinieh M; Blanc R; Burk DL; Fahiminiya S; Bareke E; Schüller U; Monoranu CM; Sträter R; Kerl K; Niederstadt T; Kurlemann G; Ellezam B; Michalak Z; Thom M; Lockhart PJ; Leventer RJ; Ohm M; MacGregor D; Jones D; Karamchandani J; Greenwood CM; Berghuis AM; Bens S; Siebert R; Zakrzewska M; Liberski PP; Zakrzewski K; Sisodiya SM; Paulus W; Albrecht S; Hasselblatt M; Jabado N; Foulkes WD; Majewski J
    Acta Neuropathol; 2016 Jun; 131(6):847-63. PubMed ID: 26920151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activating mutations in the MAP-kinase pathway define non-ossifying fibroma of bone.
    Baumhoer D; Kovac M; Sperveslage J; Ameline B; Strobl AC; Krause A; Trautmann M; Wardelmann E; Nathrath M; Höller S; Hardes J; Gosheger G; Krieg AH; Vieth V; Tirabosco R; Amary F; Flanagan AM; Hartmann W
    J Pathol; 2019 May; 248(1):116-122. PubMed ID: 30549028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of novel mutation in TRPV4 with familial nonsyndromic craniosynostosis with complete penetrance and variable expressivity.
    Gayden T; Crevier-Sorbo G; Jawhar W; Saint-Martin C; Eveleigh R; Gilardino MS; Anastasio N; Trakadis Y; Bassenden AV; Berghuis AM; Jabado N; Dudley RWR
    J Neurosurg Pediatr; 2023 Jun; 31(6):584-592. PubMed ID: 36905673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activating FGFR1 Mutations in Sporadic Pheochromocytomas.
    Welander J; Łysiak M; Brauckhoff M; Brunaud L; Söderkvist P; Gimm O
    World J Surg; 2018 Feb; 42(2):482-489. PubMed ID: 29159601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gain-of-function mutation in TRPV4 identified in patients with osteonecrosis of the femoral head.
    Mah W; Sonkusare SK; Wang T; Azeddine B; Pupavac M; Carrot-Zhang J; Hong K; Majewski J; Harvey EJ; Russell L; Chalk C; Rosenblatt DS; Nelson MT; Séguin C
    J Med Genet; 2016 Oct; 53(10):705-9. PubMed ID: 27330106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in calmodulin-binding domains of TRPV4/6 channels confer invasive properties to colon adenocarcinoma cells.
    Arbabian A; Iftinca M; Altier C; Singh PP; Isambert H; Coscoy S
    Channels (Austin); 2020 Dec; 14(1):101-109. PubMed ID: 32186440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant association between FGFR1 mutation frequency and age in central giant cell granuloma.
    Niada S; Varazzani A; Giannasi C; Fusco N; Armiraglio E; Di Bernardo A; Cherchi A; Baj A; Corradi D; Tafuni A; Parafioriti A; Ferrero S; Bianchi AE; Giannì AB; Poli T; Latif F; Brini AT
    Pathology; 2023 Apr; 55(3):329-334. PubMed ID: 36428107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple versus solitary giant cell lesions of the jaw: Similar or distinct entities?
    Schreuder WH; van der Wal JE; de Lange J; van den Berg H
    Bone; 2021 Aug; 149():115935. PubMed ID: 33771761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated osteoblastic differentiation in patient-derived dental pulp stem cells carrying a gain-of-function mutation of TRPV4 associated with metatropic dysplasia.
    Han X; Kato H; Sato H; Hirofuji Y; Fukumoto S; Masuda K
    Biochem Biophys Res Commun; 2020 Mar; 523(4):841-846. PubMed ID: 31954514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRPV4 mutations causing mixed neuropathy and skeletal phenotypes result in severe gain of function.
    Taga A; Peyton MA; Goretzki B; Gallagher TQ; Ritter A; Harper A; Crawford TO; Hellmich UA; Sumner CJ; McCray BA
    Ann Clin Transl Neurol; 2022 Mar; 9(3):375-391. PubMed ID: 35170874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of MAPK/ERK pathway proteins and KRAS mutations in adenomatoid odontogenic tumors.
    Bologna-Molina R; Ogawa I; Mosqueda-Taylor A; Takata T; Sánchez-Romero C; Villarroel-Dorrego M; Takeda Y; Mikami T
    Oral Dis; 2019 Mar; 25(2):481-487. PubMed ID: 30294831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep Sequencing in Conjunction with Expression and Functional Analyses Reveals Activation of FGFR1 in Ewing Sarcoma.
    Agelopoulos K; Richter GH; Schmidt E; Dirksen U; von Heyking K; Moser B; Klein HU; Kontny U; Dugas M; Poos K; Korsching E; Buch T; Weckesser M; Schulze I; Besoke R; Witten A; Stoll M; Köhler G; Hartmann W; Wardelmann E; Rossig C; Baumhoer D; Jürgens H; Burdach S; Berdel WE; Müller-Tidow C
    Clin Cancer Res; 2015 Nov; 21(21):4935-46. PubMed ID: 26179511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of KRAS/BRAF somatic mutations in brain and spinal cord arteriovenous malformations.
    Hong T; Yan Y; Li J; Radovanovic I; Ma X; Shao YW; Yu J; Ma Y; Zhang P; Ling F; Huang S; Zhang H; Wang Y
    Brain; 2019 Jan; 142(1):23-34. PubMed ID: 30544177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.